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Emphysematous bullaIntroduction: COPD patients with advanced disease achieve minimal or no control despite proper medical
therapy that necessitates more radical approach. The bullae accentuate the altered elastic properties of
the emphysematous lung and contribute to the expiratory flow limitation.
Objective: The aim was to evaluate the therapeutic utility and safety of transbronchial volume reduction
of emphysematous bullae in COPD patients.
Patients & methods: At the site of entry, the air from the bulla was aspirated slowly, and then 10 cm of
autologous blood was instilled into the bulla before the needle was withdrawn. Clinical, functional &
radiological assessment of bulla volume and the incidence of adverse events were evaluated.
Results: 12 male patients were enrolled in this study with mean age (±SD) 47 ± 5.6 years. The procedure
was well tolerated and not associated with any serious complications. Improvements (clinically, func-
tionally and radiologically) three months after the procedure were more obvious in patients with bullous
volume <515 ml than in patients with bullous volume >515 ml.
Conclusions: Intra-bullous blood instillation could be an effective and safe volume reduction technique of
emphysematous bullae.
 2016 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).Introduction
Chronic obstructive pulmonary disease is a widely recognized
major health problem that will be the third leading cause of death
by year 2030 [1].
COPD is a potentially preventable and treatable disease. Medical
management of COPD largely relies on smoking cessation, bron-
chodilator therapy and anti-inflammatory drugs [2]. A large num-
ber of patients with advanced disease have been seen to
deteriorate quite rapidly in their course or achieve minimal or no
control. Management of such patients includes a more radical
approach like lung transplantation or lung volume reduction surg-
eries [3].
The lung volume reduction in its initial conception hypothe-
sized the reduction of that portion of the lung which is supposed
to be physiologically nonfunctional. This portion of the lung might
also physically compromise the function of normal lung tissue
adjacent to it by compression [4].The emphysematous bullae accentuate the altered elastic prop-
erties of the emphysematous lung and, therefore, contribute to the
expiratory flow limitation. Also, it may rupture into the pleural
cavity and cause a tension pneumothorax [5,6].
The operative approach for bullectomy is variable and is depen-
dent on the anatomic details of the bullae using either a muscle-
sparing thoracotomy or a video-assisted thoracoscopic surgery
(VATS) [7].
The development of bronchoscopic techniques is an attempt to
obtain the same results as surgery for lung volume reduction. Fur-
thermore, bronchoscopic techniques could also be more suitable
for patients who might not be good candidates for surgery [8,9].
Aim of the study
The aim of this study was to assess the therapeutic effectivity
and safety of the transbronchial intra-bullous autologous blood
instillation to induce bullous contraction.
Patients and methods
A total of twenty-eight COPD patients having emphysematous
bullae were recruited from Chest Department, Tanta University(2016),
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had the typical inclusion and exclusion criteria as listed below.
COPD was diagnosed on the basis of American Thoracic Society
(ATS) guidelines [10,11].
Inclusion criteria; Emphysematous patients with large bullae
(not less than 150 ml), not complicated (no infection, bleeding or
pneumothorax) with normal pulmonary parenchyma around it
and proximal in site (don’t exceed the third generation of bronchi).
Exclusion criteria; Respiratory tract infection at least 4 weeks
prior to the study,Multiple bullae in one lung with destroyed lung
parenchyma in-between, Pulmonary hypertension of >45 mmHg,
Any general medical conditions associated with a high risk for
anesthesia or bronchoscopy and Bleeding diathesis.
Assessment of Medical Research Council [MRC] dyspnea score
[12], Chest X-ray (postero-anterior and lateral views), computed
tomography (CT chest) to confirm and to delineate the anatomy
of bulla, pulmonary function tests (PFT) and lung volumes by
plethysmography (CareFusion 234 GmbH, Jaeger, Germany), Elec-
trocardiogram (ECG), arterial blood gases (ABG) and coagulation
profile were performed before the procedure.
Clinical, radiological and functional follow up; one week and
three months after the procedure was done.
After the protocol was approved by the research ethics commit-
tee of Faculty of Medicine, Tanta University, a written informed
consent was obtained from all patients.Study procedure
A flexible bronchoscope was performed with (Pentax
EPK-i5000, Tokyo, Japan) under topical anesthesia (2% xylocaine)
and moderate sedation (7.48 ± 1.78 mg midazolam) within 10 days
after CT examination. A trans-bronchial biopsy-needle 22gauge
(ECHO-HD, 22-EBUS P, Echotip, Ultra, COOK, Ireland) was
inserted through the working channel of the bronchoscopy into
the affected segmental bronchus, reaching the site of entry
(demarcated using sagittal and coronal CT reconstruction). Being
inside the bulla was confirmed through the appearance of
expiratory air bubbles inside a vertically held syringe (partially
filled with water).
The radiologically pre-estimated volume of air was slowly aspi-
rated (We estimated the volume of bulla according to the empirical
formula of Lambert: Volume = L(Length) W(Width)  H
(Height)  0.52) [13]. A maximal of 10 ml autologous blood was
infused into the bulla with average of 8.55 ± 1.13 ml (The largest
diameter of most giant bulla encountered in this study was
12 cm so this amount was suspected to cover all the entire wall
of the collapsed bulla after aspiration of their inside air). The aver-
age procedure time was 19.75 ± 3.64 min.Table 1
The number, distribution and volume of bullae (pre- & post-procedure).
Patients Number of bullae Distribution
Group I 1 1 Left upper lobe
2 2 Right upper & left lower lobe
3 1 Left lower lobe
4 3 Right upper & lower lobes
5 1 Right upper lobe
6 2 Left upper & lower lobe
7 2 Left upper & right upper lobe
Group II 1 1 Right lower lobe
2 2 Right upper lobe & left upper lobe
3 4 Scattered on right side
4 1 Right upper lobe
5 2 Right upper lobe & small left lower on
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Descriptive statistics (mean ± SD) and standard student ‘t test’,
test of significance of the difference between two means, were
used for the statistical analysis. P value of less than 0.05 was con-
sidered to be significant. ROC-curve was used for detection of cut-
off value of bullae’s volume.Results
Twelve male patients were incorporated into this study, with
mean age (±SD) 47 ± 5.6 years. The mean pre-procedural functional
parameters were: FEV1, 1.52 ± 0.27 L [58.77 ± 6.22% predicted];
FVC, 3.11 ± 0.17 L [70.77 ± 3.25% predicted]; RV, 5.19 ± 0.29L
[212.92 ± 20.06% predicted]; TLC, 8.48 ± 0.87 L [125.17 ± 6.04%
predicted] and RV/TLC ratio, 0.60 ± 0.04.
On CT scan, the number, distribution & volume of bullae (the
volume of bulla was more precise measuring tool than its size
due to difference in geometric shape of bulla from lung to lung
using the empirical formula of Lambert [13]) were encountered
in Table 1.
The procedure was well tolerated within average time of
19.75 ± 3.64 min and was not associated with any serious compli-
cations. All patients were discharged from the hospital on the same
day.
No significant functional improvement was observed after one
week later except in only two patient as regards FEV1 improved
by 10.4% (239 ml), 8.3% (216 ml), FVC 12.1% (567 ml), 9.5%
(398 ml)) & RV 11% (310 ml), 14% (360 ml) respectively.
Functional improvement was obvious after 3 months: mean
FEV1, was improved to 1.65 ± 0.31 L [63.73 ± 8.00% predicted]
(P value 0.103); mean FVC, was improved significantly to
3.35 ± 0.22 L [76.13 ± 3.24% predicted] (P value 0.001⁄); mean RV,
was reduced to 4.96 ± 0.37 L [203.58 ± 22.99% predicted]
(P value 0.301); mean TLC was reduced significantly to
7.86 ± 0.81 L [116.07 ± 7.73% predicted] (P value 0.004⁄) and
RV/TLC ratio, became 0.64 ± 0.07 (P value 0.180).
On analyzing the volume of bulla as an essential factor affecting
the functional improvement, the results documented that bulla of
volume less than 515 ml had significant functional improvement
with the following parameters; mean FEV1, 67.99 ± 4.79% pre-
dicted which improved by +6.95% (P value 0.023); mean FVC,
77.29 ± 1.39% predicted which improved by +7.39% (P value
0.001); mean TLC, 111.40 ± 6.09% predicted reduced by 11.89%
(P value 0.003) while mean RV, 191.86 ± 19.88% predicted reduced
by 13.28% (P value 0.239) and RV/TLC became 0.64 ± 0.09
improved by 0.05 (P value 0.241) with no significance and these 7
patients were classified as (Group I). While bulla of volume more
than 515 ml (5 patients) had functional improvement but withVolume (pre) Volume (post)
320 ml 110 ml
The nearest is upper one (410 ml) 180 ml
380 ml 160 ml
The largest is lower one (390 ml) 150 ml
250 ml Less than 50 ml with linear density
The nearest is lower one (280 ml) 90 ml
The left one is (430 ml) 200 ml
550 ml 380 ml
The nearest one is 720 ml 680 ml
The nearest one is 680 ml 510 ml
520 ml 370 ml
e 610 ml No change
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Figure 1. Diagram shows the functional parameters of Group I & Group II pre- & post-procedure.
Table 2
The functional parameters of bulla volume less than 515 ml (Group I) pre- & post-procedure.
Group I Range Mean ± S. D t. test p. value
FEV1 Pre 54.8–69.1 61.04 ± 5.13 6.849 0.023*
Post 59.3–75.2 67.99 ± 4.79
FVC Pre 65.2–73.1 69.90 ± 2.59 44.341 0.001*
Post 75.7–79.3 77.29 ± 1.39
RV Pre 181–236 205.14 ± 20.19 1.539 0.239
Post 169–222 191.86 ± 19.88
TLC Pre 116–132 123.29 ± 5.71 14.188 0.003*
Post 101.4–118 111.40 ± 6.09
RV/TLC Pre 0.52–0.65 0.59 ± 0.04 1.524 0.241
Post 0.53–0.76 0.64 ± 0.09
* Significant P value < 0.05.
Table 3
The functional parameters of bulla volume more than 515 ml (Group II) pre- & post-procedure.
Group II Range Mean ± S. D t. test p. value
FEV1 Pre 47.5–65.4 55.58 ± 6.72 0.219 0.652
Post 49.2–70.1 57.78 ± 8.09
FVC Pre 67.1–76.7 71.98 ± 3.99 0.888 0.374
Post 69.3–79.7 74.52 ± 4.52
RV Pre 200–240 223.80 ± 15.51 0.138 0.720
Post 194–238 220.00 ± 16.84
TLC Pre 119–136 127.80 ± 6.06 2.502 0.152
Post 118–127.1 122.62 ± 4.11
RV/TLC Pre 0.56–0.69 0.62 ± 0.05 0.318 0.588
Post 0.55–0.68 0.64 ± 0.05
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improved only by +2.2%; mean FVC, 74.52 ± 4.52% predicted
improved by +2.54%; mean RV, 220.00 ± 16.84% predicted reduced
by 3.8%; mean TLC, 122.62 ± 4.11% predicted reduced by 5.18%
and RV/TLC became 0.64 ± 0.05 improved by 0.02 who were
described as (Group II) as shown in Fig. 1. Only 1 patient in this
group improved significantly (FEV1: +4.52%, FVC + 5.23%, RV:
9.8% & TLC: 11.2%) (Fig. 1, Tables 2& 3).
Also clinically; the MRC dyspnea scale in group I (7 patients)
(3 months later) improved by 1 point in 4 patients and 2 points
in 2 patients and no improvement in one patient. While in group
II (5 patients) it improved by 1 point in only 2 patients and no
improvement in 3 patients.
Radiologically; the mean volume of all bullae was reduced sig-
nificantly from 461.67 ± 154.03 ml (range, 250–720 ml) to
290.00 ± 212.73 ml (range, 50–680 ml) P value 0.034 ‘‘Table 1”).
Volume changes at targeted sites seen in post-procedural CT scans
were more noticed in group I than group II. In group I; images at
1 week post-procedural demonstrated a peripheral region of col-
lapse at the site of blood injection with some infiltrates. ByPlease cite this article in press as: A. Sh. Mohamed et al., Transbronchial bullo
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tissue formation with marked reduction of the diameter of bullae.
While in group II, 2 patients’ CT images at 1 week post-procedural
demonstrated partial reduction in the bulla size by about one third
of their baseline. By 3 months, there was no change in the bulla
size compared with the previous; one patient experienced only
mild reduction after 1 week becoming more obvious after
3 months but less than third of its baseline and 2 patients demon-
strated no changes. (Figs. 2 & 3).
Discussion
Bullae are emphysematous spaces that contribute to increased
lung volume and worsen the mechanical disadvantage of the inspi-
ratory muscles by increasing the residual volume (RV) and RV/TLC
ratio. Thus effective decompression of a large bulla or bullae is
important to improve the lung function of affected patients and
also to provide symptomatic relief [14,15].
A wide variety of surgical procedures have been used in the
management of bullous emphysema, such as: intra-cavity drai-us volume reduction in COPD patients, Egypt. J. Chest Dis. Tuberc. (2016),
Figure 2. CT scan images from a group I patient before (A) and after (B) treatment with blood injection by 3 months. There is a localized linear density at the site of
bronchoscopic treatment.
Figure 3. CT scan images from a group II patient before (A) and after (B) treatment with blood injection by 3 months. There is a partial reduction at the site of bronchoscopic
treatment with about its third baseline volume.
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lobectomy. However, significant post-operative morbidity and a
prolonged hospital stay were common problems [16].
Isolated decompression of bullae bronchoscopically has limited
scope. So, in such study, we applied a new procedure using autol-
ogous blood to induce volume reduction of large bullae, based on
blood potential bio-adhesive properties that could lead to collapse
of emphysematous bulla by plugging and scarring [17,18].
In this study, bullae less than 515 ml were significantly reduced
in their volume as documented radiologically with effective
improvements in lung function and dyspnea scale 3 months after
treatment. While in our experience with bullae more than
515 ml, there was less reduction in their volume with less impac-
tion on pulmonary functions and dyspnea scale suggesting a size-
related response pattern. Such result indicates that large bullae
may not respond initially and need the maneuver to be repeated.
This study is in agreement with Kanoh et al. [19] who used in
their study transbronchial intra-bullous autologous blood admixed
with fibrinogen and thrombin that achieved significant reduction
of emphysematous bullae with no re-expansion of the decom-
pressed bulla, leading to marked functional and symptomatic
relief.
Also, conceding with our study, the results of Zoumot et al. [20]
who treated 5 patients with this minimally invasive approach as
day-case procedure using moderate sedation. Three of the 5
patients had shrinkage of the bullae with significant and dramatic
improvements in quality of life, exercise capacity and lung
function.
The procedure was safe with no serious complications as pneu-
mothorax, bronchopleural fistula, lung abscess or pneumonia. ThisPlease cite this article in press as: A. Sh. Mohamed et al., Transbronchial bullo
http://dx.doi.org/10.1016/j.ejcdt.2016.10.010could be due to proximal bullae selection with the precise demar-
cation of the point of entry under CT guiding.
Recommendation; considering the small number of cases
enrolled in the study (only 12 cases) and the short period of follow
up (3 months), future studies on a large scope and for sufficient
time must be performed to standardize this technique as an
acceptable therapeutic modality and to identify the best
responders.
In conclusions, intra-bullous blood injection can be an effective,
less invasive, and safe therapeutic approach for reduction of
emphysematous bullae.References
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